Understanding diabetes after kidney transplant
Part of Hormones & metabolism clinical trials.
This study helps doctors predict who may develop complications from diabetes that appears after a kidney transplant. By understanding your individual risk, your care team can better prevent problems and keep your transplanted kidney healthy longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–70 years old
- Received a kidney transplant and developed diabetes between 1 and 10 years after transplant
- Able to provide informed consent (understand and agree to participate)
- No active cancer or ongoing infection
- No severe heart failure (NYHA class III or IV) or liver failure
- No history of the original kidney disease returning in the transplanted kidney
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with type 2 diabetes who are either waiting for a liver transplant or have already had one. Researchers want to understand how diabetes treatment affects outcomes before and after transplant.
This study looks for factors that may help predict who will develop diabetes after a kidney transplant. It is for people who have not had diabetes before their transplant and are starting on tacrolimus and steroids.
This study looks at tiny molecules called microRNAs to predict if new diabetes might develop after a kidney transplant. By measuring these molecules in your blood, researchers hope to catch early signs and improve care.
This trial tests a hybrid closed-loop system (an advanced insulin pump that automatically adjusts insulin) for people with diabetes who have had a kidney transplant. It may help improve blood sugar control and reduce the burden of managing diabetes after transplant.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
Hear when a new New Onset Diabetes After Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.